Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Neoplasms 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Multiple Myeloma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Sarcoma 2 Rectal Neoplasms 2 Radiation Injuries 2 Prostatic Neoplasms 2 Preleukemia 2 Precancerous Conditions 2 Osteosarcoma 2 Neoplasms by Histologic Type 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Multiple Chronic Conditions 2 Melanoma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Biphenotypic, Acute 2

Interventions

Diathermy 22 Radiotherapy 11 Drug Therapy 5 Cisplatin 5 Fluorouracil 4 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Doxorubicin 2 Conization 2 Capecitabine 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Therapeutics 1 Temozolomide 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Patient Reported Outcome Measures × Clear all

NCT06452485 2025-10-06

RT-HYPE

Amsterdam UMC, location VUmc

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡